Mankind Pharma Limited (NSE:MANKIND)
2,125.00
+20.60 (0.98%)
Apr 17, 2026, 3:29 PM IST
-15.67% (1Y)
| Market Cap | 877.26B -11.3% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | 412.83M |
| PE Ratio | 49.18 |
| Forward PE | 37.92 |
| Dividend | 2.00 (0.09%) |
| Ex-Dividend Date | n/a |
| Volume | 549,298 |
| Average Volume | 595,806 |
| Open | 2,112.00 |
| Previous Close | 2,104.40 |
| Day's Range | 2,102.80 - 2,132.50 |
| 52-Week Range | 1,909.70 - 2,716.50 |
| Beta | 0.39 |
| RSI | 56.82 |
| Earnings Date | May 22, 2026 |